Back to search

Interferon β‐1a for early multiple sclerosis: CHAMPS trial subgroup analyses

Data up to Jan 2025

Published2002
Citations133
References17

Total Citations Per Year

Abstract

References (17)

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

1983 • 7,404 citations

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

1996 • 2,410 citations

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1998 • 2,049 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 2,032 citations

Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

2000 • 1,497 citations

A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis

1992 • 1,254 citations

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

1997 • 1,246 citations

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

2001 • 1,077 citations

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS

1999 • 728 citations

The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple Sclerosis

1993 • 572 citations

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up

1998 • 483 citations

Isolated demyelinating syndromes : Comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis

2000 • 427 citations

Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis

1998 • 334 citations

Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination

1999 • 142 citations

Multisequence MRI in clinically isolated syndromes and the early development of MS

1999 • 114 citations

The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis.

1995 • 72 citations

Methylprednisolone and Multiple Sclerosis

1988 • 32 citations

Cited By (0)

Loading...
Interferon β‐1a for early multiple sclerosis: CHAMPS trial subgroup analyses (2002) – Annals of Neurology | Metascience Observatory Explorer